JPMorgan Downgrades United Therapeutics Corp. (UTHR) to Neutral
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
17 Buy, 11 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
JPMorgan downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Outperform to Neutral, price target lowered from $75 to $55.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $48.76 yesterday.
For more ratings news on United Therapeutics Corp. click here and for the rating history of United Therapeutics Corp. click here.
Shares of United Therapeutics Corp. closed at $48.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Limbach Holdings (LMB) to Underweight
- United Therapeutics completes enrollment in PPF lung fibrosis trial
- Nomura/Instinet Downgrades Pop Mart International Group Ltd (9992:HK) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
